IQVIA, Illumina, Mayo Clinic and Arc Institute Harness NVIDIA AI and Accelerated Computing to Transform $10 Trillion Healthcare and Life Sciences Industry J.P. Morgan Healthcare Conference—NVIDIA today announced new partnerships to transform the $10 trillion healthcare and life sciences industry by accelerating drug discovery, enhancing genomic research and pioneering advanced healthcare services with agentic and… Continue reading NVIDIA Partners With Industry Leaders to Advance Genomics, Drug Discovery and Healthcare
Tag: Morgan
Danaher CEO to Comment on Financial Performance
WASHINGTON, Jan. 13, 2025 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company’s fourth quarter 2024 performance in a presentation at the J.P. Morgan Healthcare Conference at 11:15 a.m. PT. For the fourth quarter 2024, estimated revenues are anticipated… Continue reading Danaher CEO to Comment on Financial Performance
Trillium Flow Technologies schließt Refinanzierung erfolgreich ab
STAMFORD, Conn., 13. Januar 2025 /PRNewswire/ – Trillium Flow Technologies („Trillium”), ein Portfoliounternehmen von First Reserve und ein globaler Entwickler, Hersteller und Anbieter von Aftermarket-Dienstleistungen für hochentwickelte Ventile und Pumpen, die in kritischen Infrastruktursektoren wie Kernkraft, Wasser, Abwasser und industrielle Verarbeitung eingesetzt werden, freut sich, den erfolgreichen Abschluss seiner Refinanzierung im Dezember 2024 bekannt zu… Continue reading Trillium Flow Technologies schließt Refinanzierung erfolgreich ab
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Enphase Energy, Inc.
RADNOR, Pa., Jan. 13, 2025 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Enphase Energy, Inc. (NASDAQ: ENPH) (“Enphase” or the “Company”) on behalf of all persons and entities who purchased or otherwise acquired Enphase common stock… Continue reading Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Enphase Energy, Inc.
Advanced Ceramics Market in Europe to Grow by USD 442.6 Million from 2025-2029, Driven by Use in Medical Implants and AI-Driven Market Transformation – Technavio
NEW YORK, Jan. 13, 2025 /PRNewswire/ — Report with the AI impact on market trends – The advanced ceramics market in europe size is estimated to grow by USD 442.6 million from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 3.7% during the forecast period. Use of advanced ceramics in medical… Continue reading Advanced Ceramics Market in Europe to Grow by USD 442.6 Million from 2025-2029, Driven by Use in Medical Implants and AI-Driven Market Transformation – Technavio
Centering Healthcare Institute Introduces Strategic Plan to Transform Maternal Healthcare Nationwide
BOSTON , Jan. 13, 2025 /PRNewswire/ — The Centering Healthcare Institute (CHI) is thrilled to announce the launch of its Strategic Plan, a comprehensive approach to improving maternal and infant health outcomes across the United States. With a strong focus on equity and collaboration, this plan lays the groundwork for CHI to drive meaningful, measurable change… Continue reading Centering Healthcare Institute Introduces Strategic Plan to Transform Maternal Healthcare Nationwide
NVIDIA Partners With Industry Leaders to Advance Genomics, Drug Discovery and Healthcare
SAN FRANCISCO, Jan. 13, 2025 (GLOBE NEWSWIRE) — J.P. Morgan Healthcare Conference — NVIDIA today announced new partnerships to transform the $10 trillion healthcare and life sciences industry by accelerating drug discovery, enhancing genomic research and pioneering advanced healthcare services with agentic and generative AI. The convergence of AI, accelerated computing and biological data is turning healthcare… Continue reading NVIDIA Partners With Industry Leaders to Advance Genomics, Drug Discovery and Healthcare
Trillium Flow Technologies rondt herfinanciering succesvol af
STAMFORD, Conn., 13 januari 2025 /PRNewswire/ — Trillium Flow Technologies (“Trillium”), een portfoliobedrijf van First Reserve en een wereldwijde ontwerper, fabrikant en leverancier van aftermarket-diensten voor hoogtechnologische kleppen en pompen voor gebruik in kritieke infrastructuursectoren zoals kernenergie, water, afvalwater en industriële verwerking, kondigt verheugd aan dat het haar herfinanciering succesvol heeft afgerond in december 2024.… Continue reading Trillium Flow Technologies rondt herfinanciering succesvol af
Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generation Potential Therapy for IgA Nephropathy
Presents progress and new anticipated milestones across portfolio of more than 10 assets and 6 therapeutic areas. Announces multiple advancements across the MoDETM (molecular degraders of extracellular proteins) platform and the next generation TRAPTM (targeted removal of aberrant protein) degraders, including: IgA Nephropathy (IgAN) program: First-in-human dosing with BHV-1400, a next generation TRAP degrader, achieved… Continue reading Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generation Potential Therapy for IgA Nephropathy
Akebia Therapeutics Announces Multiple Positive Business Updates
New Commercial Supply Contracts for Vafseo® (vadadustat) secured, bringing availability and dialysis organization coverage to nearly 100% of patients on dialysis in U.S. Vafseo tablets now shipping in the U.S. Plan to start Phase 3 trial in mid-2025 to potentially expand Vafseo label to include treatment of late-stage non-dialysis CKD patients Company to discuss business… Continue reading Akebia Therapeutics Announces Multiple Positive Business Updates